A technology developed at OHSU’s Casey Eye Institute that uses artificial intelligence to better identify the blinding disease retinopathy of prematurity than most human experts.

OHSU Casey Eye Institute clinicians recently performed the first CRISPR gene editing procedure within the human body as part of a clinical trial to address a blindness-causing gene mutation.

Luke Strnad, M.D., and Brian Chan, M.D., comment on a story about vulnerabilities among people who are homeless.

Carlos Crespo, Dr.P.H., on a podcast about Oregon’s response.

Peter Spencer, M.D., comments on the concerns of neurotoxicity in plants due to drought and higher levels of greenhouse gasses.

An article features the “incredible” outcome experienced by a Grants Pass resident who underwent deep brain stimulation at OHSU to treat essential tremor.

A column authored by Joel Nigg, Ph.D., notes ADHD is not a “one-size-fits-all” condition and affects children in different ways. According to Nigg, each patient and family should work with health care providers to develop a personalized treatment plan.

John Townes, M.D., and Dawn Nolt, M.D., M.P.H., were quoted about coronavirus preparations.

John Townes, M.D., and Dawn Nolt, M.D., M.P.H., were quoted about coronavirus preparations.

Nancy Elder, M.D., is quoted about face-touching.